OBELAB, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients. (NCT06250608) | OBELAB, Inc. | 2024-03-15 |
Track OBELAB, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.